Volume 84, Issue 5 pp. 611-623
Article

A hidden aggregation-prone structure in the heart of hypoxia inducible factor prolyl hydroxylase

Hamid Hadi-Alijanvand

Hamid Hadi-Alijanvand

Department of Biological Sciences, Institute for Advanced Studies in Basic Sciences (IASBS), Zanjan, Iran

Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran, Iran

Search for more papers by this author
Elizabeth A. Proctor

Elizabeth A. Proctor

Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, 02139

Search for more papers by this author
Feng Ding

Feng Ding

Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, North Carolina, 27599

Department of Physics and Astronomy, Clemson University, Clemson, South Carolina, 29634

Search for more papers by this author
Nikolay V. Dokholyan

Nikolay V. Dokholyan

Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, North Carolina, 27599

Curriculum in Bioinformatics and Computational Biology, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, North Carolina, 27599

Program in Molecular and Cellular Biophysics, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, North Carolina, 27599

Search for more papers by this author
Ali A. Moosavi-Movahedi

Corresponding Author

Ali A. Moosavi-Movahedi

Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran, Iran

Center of Excellence in Biothermodynamics, Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran, Iran

Correspondence to: Ali A. Moosavi-Movahedi, Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran. E-mail: [email protected]Search for more papers by this author
First published: 12 February 2016
Citations: 2

ABSTRACT

Prolyl hydroxylase domain-containing protein 2 (PHD2), as one of the most important regulators of angiogenesis and metastasis of cancer cells, is a promising target for cancer therapy drug design. Progressive studies imply that abnormality in PHD2 function may be due to misfolding. Therefore, study of the PHD2 unfolding pathway paves the way for a better understanding of the influence of PHD2 mutations and cancer cell metabolites on the protein folding pathway. We study the unfolding of the PHD2 catalytic domain using differential scanning calorimetry (DSC), fluorescence spectroscopy, and discrete molecular dynamics simulations (DMD). Using computational and experimental techniques, we find that PHD2 undergoes four transitions along the thermal unfolding pathway. To illustrate PHD2 unfolding events in atomic detail, we utilize DMD simulations. Analysis of computational results indicates an intermediate species in the PHD2 unfolding pathway that may enhance aggregation propensity, explaining mutation-independent PHD2 malfunction. Proteins 2016; 84:611–623. © 2016 Wiley Periodicals, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.